Finnerty J, Hussain A, Ponnuswamy A, Kamil H, Abdelaziz A
BMC Pulm Med. 2023; 23(1):462.
PMID: 37993829
PMC: 10664669.
DOI: 10.1186/s12890-023-02761-5.
Alimohamadi Y, Yekta E, Sepandi M, Sharafoddin M, Arshadi M, Hesari E
Multidiscip Respir Med. 2022; 17(1):856.
PMID: 36117876
PMC: 9472334.
DOI: 10.4081/mrm.2022.856.
Diaz M, Catalan-Caceres N, Beauperthuy T, Domingo C, Ibanez E, Morata C
J Asthma Allergy. 2022; 15:775-781.
PMID: 35707821
PMC: 9188978.
DOI: 10.2147/JAA.S354082.
Bhattarai A, Dhakal G, Shah S, Subedi A, Sah S, Mishra S
Interdiscip Perspect Infect Dis. 2022; 2022:8508489.
PMID: 35677466
PMC: 9168826.
DOI: 10.1155/2022/8508489.
Lommatzsch M, Rabe K, Taube C, Joest M, Kreuter M, Wirtz H
Respiration. 2022; 101(3):307-320.
PMID: 35231915
PMC: 8985038.
DOI: 10.1159/000518896.
Propensity-Score-Matched Evaluation of Adverse Events Affecting Recovery after COVID-19 Vaccination: On Adenovirus and mRNA Vaccines.
Son C, Jin S, Kang W
Vaccines (Basel). 2022; 10(2).
PMID: 35214742
PMC: 8875227.
DOI: 10.3390/vaccines10020284.
Understanding and Managing Severe Asthma in the Context of COVID-19.
Kong-Cardoso B, Ribeiro A, Aguiar R, Pite H, Morais-Almeida M
Immunotargets Ther. 2021; 10:419-430.
PMID: 34926333
PMC: 8675091.
DOI: 10.2147/ITT.S342636.
Impact of asthma on COVID-19 mortality in the United States: Evidence based on a meta-analysis.
Han X, Xu J, Hou H, Yang H, Wang Y
Int Immunopharmacol. 2021; 102:108390.
PMID: 34844871
PMC: 8611693.
DOI: 10.1016/j.intimp.2021.108390.
Asthma in older adults with severe coronavirus disease 2019: Clinical outcomes and predictors of mortality.
Avdeev S, Pozdnakova A, Gaynitdinova V, Chikina S, Vlasenko A
Ann Allergy Asthma Immunol. 2021; 128(2):213-215.
PMID: 34670163
PMC: 8520591.
DOI: 10.1016/j.anai.2021.10.016.
The impact of comorbid allergic airway disease on the severity and mortality of COVID-19: a systematic review and meta-analysis.
Ming W, Zuo J, Han J, Chen J
Eur Arch Otorhinolaryngol. 2021; 279(4):1675-1690.
PMID: 34519838
PMC: 8438912.
DOI: 10.1007/s00405-021-07072-1.
Asthma and COVID-19 risk: a systematic review and meta-analysis.
Sunjaya A, Allida S, Di Tanna G, Jenkins C
Eur Respir J. 2021; 59(3).
PMID: 34385278
PMC: 8361304.
DOI: 10.1183/13993003.01209-2021.
The Risk of COVID-19 Related Hospitalsation, Intensive Care Unit Admission and Mortality in People With Underlying Asthma or COPD: A Systematic Review and Meta-Analysis.
Pardhan S, Wood S, Vaughan M, Trott M
Front Med (Lausanne). 2021; 8:668808.
PMID: 34222281
PMC: 8242585.
DOI: 10.3389/fmed.2021.668808.
Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19.
Eggert L, He Z, Collins W, Lee A, Dhondalay G, Jiang S
Allergy. 2021; 77(1):173-185.
PMID: 34080210
PMC: 8222896.
DOI: 10.1111/all.14972.
Asthma in patients with suspected and diagnosed coronavirus disease 2019.
Cao L, Lee S, Krings J, Rauseo A, Reynolds D, Presti R
Ann Allergy Asthma Immunol. 2021; 126(5):535-541.e2.
PMID: 33639262
PMC: 7905379.
DOI: 10.1016/j.anai.2021.02.020.
Asthma and allergic diseases are not risk factors for hospitalization in children with coronavirus disease 2019.
Beken B, Kartal Ozturk G, Aygun F, Aydogmus C, Akar H
Ann Allergy Asthma Immunol. 2021; 126(5):569-575.
PMID: 33493639
PMC: 7825986.
DOI: 10.1016/j.anai.2021.01.018.
Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease.
Terry P, Heidel R, Dhand R
Am J Respir Crit Care Med. 2021; 203(7):893-905.
PMID: 33493416
PMC: 8017581.
DOI: 10.1164/rccm.202008-3266OC.
